HCG23
geneOn this page
Also known as dJ1077I5.3
Summary
HCG23 (HLA complex group 23, HGNC:19713) is a long non-coding RNA gene on chromosome 6p21.32.
At a glance
- GWAS associations: 31
- Clinical variants (ClinVar): 4 total
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:19713 |
| Approved symbol | HCG23 |
| Name | HLA complex group 23 |
| Location | 6p21.32 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | dJ1077I5.3 |
| Entrez | 414764 |
| RNAcentral | URS000075B48F — lncRNA, 615 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 0
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
None — 0 exons
Expression profiles
Top tissues by expression
0 total, by Bgee expression score (0-100, higher = more expressed):
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Canonical reviewed UniProt: None (reviewed: )
All UniProt accessions (0):
RefSeq proteins (0): (*=MANE)
Domains & families (InterPro)
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 0 (showing top):
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
0 interactions, top by confidence:
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
4 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000365591 (6:32388895 C>T), RS1000388513 (6:32391728 G>A), RS1000738756 (6:32391924 C>G,T), RS1000819615 (6:32388690 G>A), RS1002093836 (6:32389856 T>C), RS1002828812 (6:32393095 T>C), RS1003103966 (6:32393384 C>T), RS1004366463 (6:32390930 C>A), RS1004402662 (6:32391252 A>G), RS1006044169 (6:32392723 T>G), RS1006073924 (6:32393047 C>G), RS1006874935 (6:32389199 C>G), RS1007420215 (6:32388955 G>T), RS1007740928 (6:32389293 C>T), RS1008959242 (6:32390540 T>A,C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
31 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001942_21 | Prostate cancer | 5.000000e-09 |
| GCST003773_15 | Loneliness (multivariate analysis) | 2.000000e-06 |
| GCST004122_3 | Fibrinogen levels | 9.000000e-09 |
| GCST004521_1 | Autism spectrum disorder or schizophrenia | 2.000000e-16 |
| GCST004521_10 | Autism spectrum disorder or schizophrenia | 2.000000e-13 |
| GCST004521_118 | Autism spectrum disorder or schizophrenia | 3.000000e-15 |
| GCST004521_126 | Autism spectrum disorder or schizophrenia | 2.000000e-10 |
| GCST004521_13 | Autism spectrum disorder or schizophrenia | 2.000000e-12 |
| GCST004521_130 | Autism spectrum disorder or schizophrenia | 2.000000e-10 |
| GCST004521_143 | Autism spectrum disorder or schizophrenia | 2.000000e-09 |
| GCST004521_17 | Autism spectrum disorder or schizophrenia | 2.000000e-12 |
| GCST004521_170 | Autism spectrum disorder or schizophrenia | 4.000000e-14 |
| GCST004521_173 | Autism spectrum disorder or schizophrenia | 4.000000e-14 |
| GCST004521_179 | Autism spectrum disorder or schizophrenia | 3.000000e-11 |
| GCST004521_211 | Autism spectrum disorder or schizophrenia | 5.000000e-15 |
| GCST004521_226 | Autism spectrum disorder or schizophrenia | 4.000000e-12 |
| GCST004521_228 | Autism spectrum disorder or schizophrenia | 4.000000e-11 |
| GCST004521_296 | Autism spectrum disorder or schizophrenia | 6.000000e-18 |
| GCST004521_81 | Autism spectrum disorder or schizophrenia | 1.000000e-14 |
| GCST004521_85 | Autism spectrum disorder or schizophrenia | 1.000000e-12 |
| GCST004750_61 | Squamous cell lung carcinoma | 6.000000e-15 |
| GCST004923_2 | Tuberculosis | 8.000000e-11 |
| GCST006252_5 | Childhood steroid-sensitive nephrotic syndrome | 9.000000e-07 |
| GCST007876_87 | Estimated glomerular filtration rate | 7.000000e-09 |
| GCST008916_16 | Asthma | 3.000000e-17 |
| GCST008916_27 | Asthma | 5.000000e-31 |
| GCST008916_90 | Asthma | 4.000000e-15 |
| GCST011359_1 | Venous thromboembolism | 4.000000e-38 |
| GCST012230_428 | Waist-to-hip ratio adjusted for BMI | 2.000000e-08 |
| GCST90020025_766 | Waist-to-hip ratio adjusted for BMI | 6.000000e-10 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007865 | loneliness measurement |
| EFO:0007788 | BMI-adjusted waist-hip ratio |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
2 total (human), top 2 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Tobacco Smoke Pollution | decreases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): nephrotic syndrome, tuberculosis, venous thromboembolism